Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis

Post time The day before yesterday 21:20

journal：Hepatology

Authors：Adrielly Martins; Nidah S. Khakoo; Anish Reddy; John M. Reynolds; Christophe Corpechot; Alexandra Rousseau; M. Hassan Murad; Shahnaz Sultan; Cynthia Levy

Published date：2026-4-

DOI：10.1097/hep.0000000000001465

PDF link：https://journals.lww.com/10.1097/HEP.0000000000001465

Article link：https://doi.org/10.1097/hep.0000000000001465

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time The day before yesterday 21:20

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Ovid] Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Ovid] Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Ovid] Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis